Dow Up 0.00% Nasdaq Up 0.09%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.66 Down 0.24(3.48%) Nov 28, 1:00PM EST
Prev Close:6.90
Open:6.90
Bid:6.60 x 100
Ask:6.71 x 100
1y Target Est:10.33
Beta:3.45
Next Earnings Date:N/A
Day's Range:6.64 - 6.94
52wk Range:5.22 - 13.64
Volume:144,726
Avg Vol (3m):630,444
Market Cap:291.09M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 3.48%291.09M
BAXUp 0.83%39.56B
CFNDown 0.08%12.07B
HSPDown 1.08%10.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Dec-14) :-0.30
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback